{"id":529579,"date":"2021-02-09T22:48:01","date_gmt":"2021-02-09T22:48:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=529579"},"modified":"2021-02-09T22:48:01","modified_gmt":"2021-02-09T22:48:01","slug":"opioid-withdrawal-syndrome-ows-market-analysis-leading-companies-emerging-drugs-and-epidemiology-forecast","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/opioid-withdrawal-syndrome-ows-market-analysis-leading-companies-emerging-drugs-and-epidemiology-forecast_529579.html","title":{"rendered":"Opioid Withdrawal Syndrome (OWS) Market Analysis, Leading Companies, Emerging Drugs, and Epidemiology Forecast"},"content":{"rendered":"
\"Opioid<\/a><\/p>\n
\n
Delveinsight Business Research LLP<\/p>\n<\/div>\n<\/div>\n<\/div>\n
DelveInsight’s “Opioid Withdrawal Syndrome (OWS) Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Opioid Withdrawal Syndrome (OWS), historical and forecasted epidemiology as well as the Opioid Withdrawal Syndrome (OWS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<\/div>\n

According to the American Addiction Centers, when the use of opiate drugs is stopped, it may produce several withdrawal symptoms and collectively these symptoms are called Opiate Withdrawal Syndrome (OWS)<\/strong>. Opiate withdrawal symptoms may range from mild to severe, depending on how dependent the individual is on an opioid drug.<\/p>\n

Some of the psychological withdrawal symptoms and cravings for opioid drugs may persist longer than a week in some cases. The withdrawal symptoms are generally not life-threatening, but it causes a tremendous psychological and physical disturbance that often people start reuse of opioids to avoid withdrawal symptoms. This leads to a continuous cycle of stopping and resuming drug use, which makes it difficult to quit later on.<\/p>\n

According to the survey by Roger et al. (2014), 56.5% of participants accepted that avoiding withdrawal was their primary current reason for use of opioids.<\/strong><\/p>\n

Get FREE sample copy at: 
https:\/\/www.delveinsight.com\/sample-request\/opioid-withdrawal-syndrome-market<\/a><\/strong><\/p>\n

The Opioid Withdrawal Syndrome (OWS) market report<\/strong> also covers emerging drugs, current treatment practices, <\/span>Opioid Withdrawal Syndrome (OWS) market share of the individual therapies, current and forecasted Opioid Withdrawal Syndrome (OWS) Market Size<\/span> from 2017 to 2030 segmented by seven major markets. <\/span><\/p>\n

The report provides a detailed current <\/span>Opioid Withdrawal Syndrome (OWS) treatment practice<\/span><\/strong>\/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market. <\/span><\/p>\n

 <\/p>\n

\"Opioid<\/span><\/span><\/p>\n

 <\/p>\n

Opioid Withdrawal Syndrome (OWS) Market Key Facts<\/strong><\/p>\n

According to the Centers for Disease Control and <\/strong>Prevention, the opioid prescription rate was 75.6% per <\/strong>100 people in 2014, which decreases to 58.7% per 100 <\/strong>people in 2017. Some counties had an opioid prescription<\/strong>
rate seven times higher than the national average.<\/strong><\/p>\n

In 2017, more than 72,000 Americans died from drug overdoses, including illicit drugs and prescription opioids, a 2-fold increase in a decade. The sharpest increase involved synthetic opioids, primarily fentanyl and fentanyl analogs (similar compounds), with nearly 30,000 overdose deaths, according to the Centers for Disease Control and Prevention.<\/p>\n

As per the article by Galofaro et al., the title “AP: Purdue foreign arm caught up in opioid probe in Europe,” Italian consumption of prescription opioids went from 1.1 daily doses per thousand people in 2005 to 4.5 daily doses per thousand people in 2017.<\/p>\n

Key Benefits of Opioid Withdrawal Syndrome (OWS) Market Report<\/strong><\/p>\n